T-cell Covid vaccine may last longer than current jabs: Indian-American researcher

Pennsylvania State University researchers in the US partnered with Evaxion Biotech on a study that was the first to demonstrate the effectiveness of an AI-generated vaccine in a live viral challenge model.

Related Keywords

New York ,United States ,American ,Girish Kirimanjeswara ,Pennsylvania State University ,T Cell Covid ,Evaxion Biotech ,Covid ,Covid Vaccine ,Covid 19 ,Indian American ,Ars Cov 2 ,